Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population

BACKGROUND: Hepatitis C virus (HCV) treatment regimens (DAAs) are well tolerated, efficacious but costly. Their high cost and restricted availability, raises concerns about the outcome of treatment in uninsured patients. This study investigated sustained virologic response (SVR) outcomes in a predom...

Descripción completa

Detalles Bibliográficos
Autores principales: DeBose-Scarlett, Alexandra, Balise, Raymond, Kwon, Deukwoo, Vadaparampil, Susan, Chen, Steven Xi, Schiff, Eugene R., Ayala, Gladys Patricia, Thomas, Emmanuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027772/
https://www.ncbi.nlm.nih.gov/pubmed/29954391
http://dx.doi.org/10.1186/s12967-018-1555-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027772/
https://www.ncbi.nlm.nih.gov/pubmed/29954391
http://dx.doi.org/10.1186/s12967-018-1555-y

Ejemplares similares